L-TRYPTOPHAN ADMINISTRATION IN L-DOPA-INDUCED HALLUCINATIONS

被引：0
|
作者：
RABEY, JM
VARDI, J
ASHKENAZI, JJ
STREIFLER, M
机构：
[1] ICHILOV MUNICIPAL GOVT HOSP,TEL AVIV,ISRAEL
[2] SACKLER SCH MED,TEL AVIV,ISRAEL
来源：
ISRAEL JOURNAL OF MEDICAL SCIENCES | 1976年 / 12卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1518 / 1519
页数：2
相关论文
共 50 条
  • [1] L-TRYPTOPHAN ADMINISTRATION IN L-DOPA-INDUCED HALLUCINATIONS IN ELDERLY PARKINSONIAN PATIENTS
    RABEY, JM
    VARDI, J
    ASKENAZI, JJ
    STREIFLER, M
    [J]. GERONTOLOGY, 1977, 23 (06) : 438 - 444
  • [2] EFFECT OF L-TRYPTOPHAN ON L-DOPA ABSORPTION
    WEITBRECHT, WU
    WEIGEL, K
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (01) : 20 - 22
  • [3] L-DOPA-INDUCED ASTERIXIS
    KOBAYASHI, I
    OSAWA, M
    OHTA, K
    MARUYAMA, S
    [J]. FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1985, 39 (04): : 507 - 513
  • [4] L-DOPA-induced dyskinesia
    Derkinderen, P
    Vidailhet, M
    [J]. REVUE NEUROLOGIQUE, 2002, 158 : S92 - S101
  • [5] The evolution of L-dopa-induced dyskinesia in relation to L-dopa dose magnitude and frequency of administration
    Tsironis, C
    Marselos, M
    Konitsiotis, S
    [J]. MOVEMENT DISORDERS, 2006, 21 : S73 - S74
  • [6] The pathophysiology of L-DOPA-induced dyskinesia
    Brotchie, JM
    [J]. MOVEMENT DISORDERS, 2004, 19 : S11 - S11
  • [7] BETA-ADRENOCEPTOR ANTAGONISTS IN L-TRYPTOPHAN AND L-DOPA INDUCED BEHAVIORAL SYNDROMES
    BUXTON, DA
    FRIEND, J
    KENT, AP
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1980, 68 (01) : P176 - P177
  • [8] Mirtazapine in L-dopa-induced dyskinesias
    Fabrizio, E
    Vanacore, N
    Pratesi, L
    Di Rezze, S
    Alessandri, A
    Meco, G
    [J]. MOVEMENT DISORDERS, 2002, 17 : S107 - S107
  • [9] Levetiracetam in L-dopa-induced dyskinesia
    Meco, G
    Fabrizio, E
    Epifanio, A
    Di Raimondo, G
    Vanacore, N
    Morgante, L
    [J]. CLINICAL NEUROPHARMACOLOGY, 2005, 28 (02) : 102 - 103
  • [10] Mirtazapine in L-dopa-induced dyskinesias
    Meco, G
    Fabrizio, E
    Di Rezze, S
    Alessandri, A
    Pratesi, L
    [J]. CLINICAL NEUROPHARMACOLOGY, 2003, 26 (04) : 179 - 181
12345